Methylprednisolone in adults hospitalized with COVID-19 pneumoniaAn open-label randomized trial (GLUCOCOVID)

被引：0
|
作者：
Luis Corral-Gudino
Alberto Bahamonde
Francisco Arnaiz-Revillas
Julia Gómez-Barquero
Jesica Abadía-Otero
Carmen García-Ibarbia
Víctor Mora
Ana Cerezo-Hernández
José L. Hernández
Graciela López-Muñíz
Fernando Hernández-Blanco
Jose M. Cifrián
Jose M. Olmos
Miguel Carrascosa
Luis Nieto
María Carmen Fariñas
José A. Riancho
机构：
[1] Universidad de Valladolid,Hospital Rio Hortega, Servicio de Medicina Interna
[2] Hospital Bierzo,Servicio de Medicina Interna
[3] Universidad de Cantabria,IDIVAL, Hospital U M Valdecilla, Servicio de Enfermedades Infecciosas
[4] Universidad de Valladolid,Hospital Rio Hortega, Servicio de Medicina Interna, Consulta de Enfermedades Infecciosas
[5] Universidad de Cantabria,IDIVAL, Hospital U M Valdecilla, Servicio de Medicina Interna
[6] Universidad de Cantabria,IDIVAL, Hospital U M Valdecilla, Servicio de Neumología
[7] Hospital Universitario Río Hortega,Servicio de Neumología
[8] Hospital Laredo,Servicio de Medicina Interna
[9] Hospital Sierrallana,Servicio de Medicina Interna
来源：
Wiener klinische Wochenschrift | 2021年 / 133卷
关键词：
Glucocorticoids; SARS-CoV-2; Mortality; Coronavirus Infections; Humans;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：303 / 311
页数：8
相关论文
共 50 条
  • [31] Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
    Gautret, Philippe
    Lagier, Jean-Christophe
    Parola, Philippe
    Van Thuan Hoang
    Meddeb, Line
    Mailhe, Morgane
    Doudier, Barbara
    Courjon, Johan
    Giordanengo, Valerie
    Vieira, Vera Esteves
    Dupont, Herve Tissot
    Honore, Stephane
    Colson, Philippe
    Chabriere, Eric
    La Scola, Bernard
    Rolain, Jean-Marc
    Brouqui, Philippe
    Raoult, Didier
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (01)
  • [32] Ozanimod Therapy in Patients With COVID-19 Requiring Oxygen Support A Randomized Open-Label Pilot Trial
    Lellouche, Francois
    Blais-Lecours, Pascale
    Maltais, Francois
    Sarrazin, Jean-Francois
    Rola, Philippe
    Nguyen, Tuyen
    Chateauvert, Nathalie
    Marsolais, David
    CHEST, 2024, 165 (04) : 810 - 819
  • [33] An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients
    Álvaro Réa-Neto
    Rafaella Stradiotto Bernardelli
    Bruna Martins Dzivielevski Câmara
    Fernanda Baeumle Reese
    Marcos Vinicius Oliveira Queiroga
    Mirella Cristine Oliveira
    Scientific Reports, 11
  • [34] Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia A Randomized Clinical Trial
    Collins, Sean P.
    Shotwell, Matthew S.
    Strich, Jeffrey R.
    Gibbs, Kevin W.
    de Wit, Marjolein
    Files, D. Clark
    Harkins, Michelle
    Hudock, Kris
    Merck, Lisa H.
    Moskowitz, Ari
    Apodaca, Krystle D.
    Barksdale, Aaron
    Safdar, Basmah
    Javaheri, Ali
    Sturek, Jeffrey M.
    Schrager, Harry
    Iovine, Nicole M.
    Tiffany, Brian
    Douglas, Ivor
    Levitt, Joseph
    Ginde, Adit A.
    Hager, David N.
    Shapiro, Nathan
    Duggal, Abhijit
    Khan, Akram
    Lanspa, Michael
    Chen, Peter
    Gentile, Nina
    Harris, Estelle
    Gong, Michelle
    Sellers, Subhashini
    Goodwin, Andrew J.
    Tidswell, Mark A.
    Filbin, Michael
    Desai, Neeraj
    Gutierrez, Felix
    Estrada, Vicente
    Burgos, Joaquin
    Boyles, Tom
    Pano-Pardo, Jose R.
    Hussen, Nazreen
    Rosenberg, Yves
    Troendle, James
    Bernard, Gordon R.
    Bistran-Hall, Amanda J.
    Walsh, Kelly
    Casey, Jonathan D.
    Declercq, Josh
    Joly, Meghan Morrison
    Pulley, Jill
    JAMA NETWORK OPEN, 2024, 7 (12)
  • [35] Melatonin effects on sleep quality and outcomes of COVID-19 patients: An open-label, randomized, controlled trial
    Mousavi, Seyed Abbas
    Heydari, Keyvan
    Mehravaran, Hossein
    Saeedi, Majid
    Alizadeh-Navaei, Reza
    Hedayatizadeh-Omran, Akbar
    Shamshirian, Amir
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (01) : 263 - 271
  • [36] Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial
    Elisabeth De Leeuw
    Karel F. A. Van Damme
    Jozefien Declercq
    Cedric Bosteels
    Bastiaan Maes
    Simon J. Tavernier
    Laurent Detalle
    Trevor Smart
    Sophie Glatt
    Nincy Debeuf
    Julie Deckers
    Sahine Lameire
    Stefaan J. Vandecasteele
    Nikolaas De Neve
    Ingel K. Demedts
    Elke Govaerts
    Christiane Knoop
    Karolien Vanhove
    Michel Moutschen
    Wim Terryn
    Pieter Depuydt
    Eva Van Braeckel
    Filomeen Haerynck
    Tine C. J. Hendrickx
    Vanessa Parrein
    Marianna Lalla
    Claire Brittain
    Bart N. Lambrecht
    Respiratory Research, 23
  • [37] Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial
    De Leeuw, Elisabeth
    Van Damme, Karel F. A.
    Declercq, Jozefien
    Bosteels, Cedric
    Maes, Bastiaan
    Tavernier, Simon J.
    Detalle, Laurent
    Smart, Trevor
    Glatt, Sophie
    Debeuf, Nincy
    Deckers, Julie
    Lameire, Sahine
    Vandecasteele, Stefaan J.
    De Neve, Nikolaas
    Demedts, Ingel K.
    Govaerts, Elke
    Knoop, Christiane
    Vanhove, Karolien
    Moutschen, Michel
    Terryn, Wim
    Depuydt, Pieter
    Van Braeckel, Eva
    Haerynck, Filomeen
    Hendrickx, Tine C. J.
    Parrein, Vanessa
    Lalla, Marianna
    Brittain, Claire
    Lambrecht, Bart N.
    RESPIRATORY RESEARCH, 2022, 23 (01)
  • [38] Subcutaneous Sarilumab in Hospitalized Patients with Moderate-severe COVID-19 Infection Compared to the Standard Care: An Open-label Randomized Clinical Trial
    Rodriguez-Garcia, Sebastian C.
    Gonzalez-Alvaro, Isidoro
    Abad-Santos, Francisco
    Bautista-Hernandez, Azucena
    Garcia-Fraile, Lucio
    Pablo Baldivieso-Acha, Juan
    Sanz-Sanz, Jesus
    Garcia de Vicuna, Rosario
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 167 - 170
  • [39] Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial
    Marcos-Jubilar, Maria
    Carmona-Torre, Francisco
    Vidal, Rosa
    Ruiz-Artacho, Pedro
    Filella, David
    Carbonell, Cristina
    Jimenez-Yuste, Victor
    Schwartz, Juana
    Llamas, Pilar
    Alegre, Felix
    Sadaba, Belen
    Nunez-Cordoba, Jorge
    Yuste, Jose R.
    Fernandez-Garcia, Javier
    Lecumberri, Ramon
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (02) : 295 - 299
  • [40] Effect of Tenofovir Alafenamide Fumarate on the outcomes of hospitalized COVID-19 patients: a prospective, block-balanced, open-label, randomized controlled trial
    Pouri, Nazanin Yazdan
    Eshkiki, Zahra Shokati
    Talebi, Afshin
    Cheraghian, Bahman
    Ahmadi, Fatemeh
    Neisi, Niloofar
    Shayesteh, Ali Akbar
    BMC PHARMACOLOGY & TOXICOLOGY, 2024, 25 (01):
12345